Massachusetts Financial Services
LGND icon

Massachusetts Financial Services’s Ligand Pharmaceuticals LGND Stock Holding History

Massachusetts Financial Services’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$119M Sell
375,762
-35,781
-9% -$8.43M 0.04% 369
2026
Q1 		$82.2M Sell
411,543
-95,476
-19% -$18.9M 0.03% 398
2025
Q4 		$95.9M Sell
507,019
-34,826
-6% -$6.69M 0.03% 387
2025
Q3 		$96M Buy
541,845
+202,103
+59% +$30M 0.03% 380
2025
Q2 		$38.6M Buy
339,742
+61,951
+22% +$6.62M 0.01% 522
2025
Q1 		$29.2M Buy
277,791
+1,060
+0.4% +$120K 0.01% 548
2024
Q4 		$29.7M Buy
+276,731
New +$31.3M 0.01% 547

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Massachusetts Financial Services's LGND Position: Q2 2026 in Review

Massachusetts Financial Services reduced its Ligand Pharmaceuticals (LGND) stake by 8.7% in Q2 2026, selling an estimated $8.43M and leaving 375,762 shares worth $119M. The position accounts for 0.04% of the portfolio, ranked #369.

Massachusetts Financial Services first reported a position in LGND in Q4 2024 and has held it in 7 quarters since. 416 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • Massachusetts Financial Services held 375,762 shares of Ligand Pharmaceuticals worth $119M as of Q2 2026.
  • Massachusetts Financial Services sold 35,781 Ligand Pharmaceuticals shares in Q2 2026, an estimated $8.43M.
  • Ligand Pharmaceuticals made up 0.04% of Massachusetts Financial Services's portfolio in Q2 2026, its #369 holding.
  • Massachusetts Financial Services first reported a position in Ligand Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 416 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Massachusetts Financial Services's 13F filing for Q2 2026, filed 3 Aug 2026.